LMO1 polymorphisms reduce neuroblastoma risk in Chinese children: a two-center case-control study-Reference-Cited by-同舟云学术

LMO1 polymorphisms reduce neuroblastoma risk in Chinese children: a two-center case-control study

Published:2017-08-07 Issue:39 Volume:8 Page:65620-65626
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Jiao¹,Lin Huiran²,Wang Jiaxiang¹,He Jing³,Zhang Da¹,Qin Pan¹,Yang Lin¹,Yan Lizhao¹

Affiliation:

1. Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China

2. Animal Experimental Management Center, Public Technology Service Platform, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, China

3. Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study;BMC Cancer;2024-06-27

2. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types;Chinese Medical Journal;2021-04-16

3. LncRNA cancer susceptibility candidate (CASC7) upregulates phosphatase and tensin homolog by downregulating miR-10a to inhibit neuroblastoma cell proliferation;NeuroReport;2020-03-25

4. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta‐analysis of case‐control studies;Journal of Cellular and Molecular Medicine;2019-12-12

5. APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study;Oxidative Medicine and Cellular Longevity;2019-06-25